Preoperative Carbohydrate Drink in Adolescent Idiopathic Scoliosis Surgery: the Impact on Safety and Enhanced Recovery
Launched by UNIVERSITY OF MALAYA · Nov 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving a carbohydrate drink to teenagers before scoliosis surgery can help improve their recovery and overall experience. The researchers want to find out if this drink can help with issues like stomach problems, reduce feelings of nausea after surgery, and speed up the return of normal bowel function. They are also looking at whether it can help patients feel less anxious, thirsty, or hungry, and even shorten their hospital stay.
To participate in this study, patients must be between 10 and 19 years old and diagnosed with adolescent idiopathic scoliosis, which means their spine has an abnormal curve without a known cause. They need to be undergoing a specific type of surgery called single-staged posterior spinal fusion. However, those with diabetes, intellectual disabilities, or certain other health issues will not be eligible. If chosen to participate, patients can expect to receive a carbohydrate drink before their surgery and be closely monitored to see how it affects their recovery. This study aims to improve surgical outcomes and make the recovery process smoother for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient diagnosed with idiopathic scoliosis undergoing single-staged posterior spinal fusion
- • Age between 10 to 19 years old
- • ASA 1 \& 2
- Exclusion Criteria:
- • Patient diagnosed with diabetes mellitus (either type I or type II)
- • Patient with intellectual disability
- • American Society of Anesthesiologists (ASA) class 3 and above
- • Significant risk of aspiration (diagnosed with hiatal hernia, presence of GERD, BMI \> 35 kg/m2 , poor GCS, swallowing abnormality, gastrointestinal abnormality)
About University Of Malaya
The University of Malaya, a premier research institution in Malaysia, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the University collaborates with leading healthcare professionals and researchers to explore cutting-edge treatments and interventions. Its clinical trial programs focus on various health challenges, aiming to translate scientific discoveries into practical applications that benefit diverse populations. By fostering a multidisciplinary approach, the University of Malaya continues to contribute significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuala Lumpur, , Malaysia
Pantai Valley, Kuala Lumpur, Malaysia
Patients applied
Trial Officials
Siti Nadzrah B Yunus, MBBS
Principal Investigator
Universiti Malaya
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported